IBIO Earnings

IBIO reported its FY2024Q3 earnings on 2024-05-13, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was -0.71, surpassing the expected 0 by 0%. The stock experienced a -1.62% price change on the earnings day and a 7.03% change over the next five days, reflecting market reactions to the results.

Following IBIO's FY2024Q3 earnings announcement on 2024-05-13, the stock price moved by -1.62% on the day of the release. Over the subsequent five days, it saw a 7.03% change. Historically, IBIO's stock price tends to shift by an average of -8.56% in the 10 days leading up to earnings and 31.65% in the 10 days following, providing insight into potential market.

For 2026/Q3, analysts estimate IBIO's annual revenue to reach 25.00K, while the EPS is projected at -0.06. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between IBIO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IBIO's stock price typically moves by -8.56% in the 10 days before its earnings and 31.65% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of -0.06 and revenue of 25.00K.

The earnings call presents mixed signals. The basic financial performance shows significant increases in R&D and G&A expenses, indicating investment but also higher costs. The Q&A reveals a strategic shift in vaccine development, which could be positive, but also delays. The lack of clear timelines and details in management responses raises concerns. A reverse stock split could improve stock perception but may not immediately impact fundamentals. Overall, the sentiment is neutral due to balanced positive and negative factors.